ascopubs.org

Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With ...

Patients With Merkel Cell Carcinoma Tumors ≤ 1.0 cm in Diameter Are Unlikely to Harbor Regional Lymph Node Metastasis This trial included patients with metastatic or locally advanced pancreatic cancer ...
ascopubs.org

Concurrent chemoradiotherapy with gemcitabine and S-1 for unresectable locally advanced pancreatic adenocarcinoma: A phase I study.

Gemcitabine (G) fixed-dose-rate infusion (FDR) plus erlotinib (E) in patients with advanced pancreatic cancer (APC). Background: The primary objective of this study is to assess the toxicity of ...
The American Journal of Managed Care

FDA Approves Pembrolizumab Plus Gemcitabine, Cisplatin for Locally Advanced Unresectable or Metastatic Biliary Tract Cancer

The approval, which is based on results from the phase 3 KEYNOTE-966 trial, marks the sixth indication for pembrolizumab in gastrointestinal cancer. The FDA has approved pembrolizumab (Keytruda; Merck ...
MarketWatch

Eli Lilly submits Gemzar for expanded use in Europe

Eli Lilly said it has filed regulatory submissions in Europe for an expanded indication of its breast cancer treatment Gemzar. The company said the submissions are based on an analysis of Phase III ...